Abstract

Previous studies have linked the evolution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic variants to persistent infections in people with immunocompromising conditions, but the processes responsible for these observations are incompletely understood. Here we use high-throughput, single-genome amplification and sequencing (HT-SGS) to sequence SARS-CoV-2 spike genes from people with HIV (PWH, n = 22) and people without HIV (PWOH, n = 25). In PWOH and PWH with CD4 T cell counts (i.e., CD4 counts) ≥ 200 cells/μL, we find that most SARS-CoV-2 genomes sampled in each person share one spike sequence. By contrast, in people with advanced HIV infection (i.e., CD4 counts < 200 cells/μL), HT-SGS reveals a median of 46 distinct linked groupings of spike mutations per person. Elevated intra-host spike diversity in people with advanced HIV infection is detected immediately after COVID-19 symptom onset, and early intra-host spike diversity predicts SARS-CoV-2 shedding duration among PWH. Analysis of longitudinal timepoints reveals rapid fluctuations in spike sequence populations, replacement of founder sequences by groups of new haplotypes, and positive selection at functionally important residues. These findings demonstrate remarkable intra-host genetic diversity of SARS-CoV-2 in advanced HIV infection and suggest that adaptive intra-host SARS-CoV-2 evolution in this setting may contribute to the emergence of new variants of concern.

High-throughput, single-copy sequencing of SARS-CoV-2 spike in a longitudinal cohort of people with and without HIV infection demonstrates striking intra-host diversity and adaptive evolution of SARS-CoV-2 in people with advanced HIV infection.

Details

Title
Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection
Author
Ko, Sung Hee 1   VIAFID ORCID Logo  ; Radecki, Pierce 1   VIAFID ORCID Logo  ; Belinky, Frida 1 ; Bhiman, Jinal N. 2   VIAFID ORCID Logo  ; Meiring, Susan 3   VIAFID ORCID Logo  ; Kleynhans, Jackie 4   VIAFID ORCID Logo  ; Amoako, Daniel 5   VIAFID ORCID Logo  ; Guerra Canedo, Vanessa 1 ; Lucas, Margaret 1   VIAFID ORCID Logo  ; Kekana, Dikeledi 6 ; Martinson, Neil 7 ; Lebina, Limakatso 8 ; Everatt, Josie 3 ; Tempia, Stefano 4   VIAFID ORCID Logo  ; Bylund, Tatsiana 1 ; Rawi, Reda 1   VIAFID ORCID Logo  ; Kwong, Peter D. 1   VIAFID ORCID Logo  ; Wolter, Nicole 9   VIAFID ORCID Logo  ; von Gottberg, Anne 10   VIAFID ORCID Logo  ; Cohen, Cheryl 4   VIAFID ORCID Logo  ; Boritz, Eli A. 1   VIAFID ORCID Logo 

 National Institutes of Health, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165) 
 a division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa (GRID:grid.94365.3d) (ISNI:0000 0004 0630 4646); University of the Witwatersrand, SAMRC Antibody Immunity Research Unit, Faculty of Health Sciences, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 1937 1135) 
 a division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 0630 4646) 
 a division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 0630 4646); University of the Witwatersrand, School of Public Health, Faculty of Health Sciences, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 1937 1135) 
 a division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 0630 4646); University of Guelph, Department of Integrative Biology and Bioinformatics, College of Biological Sciences, Ontario, Canada (GRID:grid.34429.38) (ISNI:0000 0004 1936 8198) 
 a division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa (GRID:grid.94365.3d) (ISNI:0000 0004 0630 4646) 
 University of the Witwatersrand, Perinatal HIV Research Unit, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 1937 1135); Center for TB Research, Johns Hopkins University, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 University of the Witwatersrand, Perinatal HIV Research Unit, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 1937 1135) 
 a division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa (GRID:grid.94365.3d) (ISNI:0000 0004 0630 4646); University of the Witwatersrand, School of Pathology, Faculty of Health Sciences, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 1937 1135) 
10  a division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 0630 4646); University of the Witwatersrand, School of Pathology, Faculty of Health Sciences, Johannesburg, South Africa (GRID:grid.11951.3d) (ISNI:0000 0004 1937 1135) 
Pages
7240
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3095826144
Copyright
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.